Pharmacy Times Continuing Education™ to Present Specialty Pharmacy CE Symposia in Las Vegas

PTCE will offer 15 CE sessions at the 2019 Asembia Specialty Pharmacy
Summit

CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Asembia19?src=hash" target="_blank"gt;#Asembia19lt;/agt;–Pharmacy Times Continuing Education™ (PTCE), a leader in
continuing education for retail, health-system, managed care and
specialty pharmacists, will conduct 15 CE-accredited sessions in
conjunction with the 15th annual Asembia Specialty Pharmacy Summit at
the Wynn and Encore Hotels in Las Vegas, Nevada. The summit will be held
from Monday, April 29, to Thursday, May 2, 2019.

“We are pleased once again for the opportunity to present our CE
sessions to all attendees during this year’s Asembia Specialty Pharmacy
Summit,” said Jim Palatine, RPh, MBA, president of PTCE.
“The meeting is home to thousands of specialty pharmacy professionals,
and we look forward to offering these free CE sessions to those
registered for the Summit.”

The topics of PTCE’s sessions are:

• Pulmonary Arterial Hypertension, which will be held on
  Monday, April 29, from 11:30 a.m. to 1 p.m. This activity is supported
  by an education grant from Bayer HealthCare Pharmaceuticals Inc.
• Hereditary Angioedema, which will be held on
  Monday, April 29, from 2 p.m. to 3:30 p.m. This activity is supported
  by an education grant from CSL Behring.
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), which
  will be held on Monday, April 29, from 4:30 p.m. to 6:00
  p.m. This activity is supported by an education grant from CSL Behring.
• PCSK9 Inhibitors, which will be held on Monday,
  April 29, from 7 p.m. to 8:30 p.m. This activity is supported by an
  education grant from Amgen.
• Inflammatory Bowel Disease, which will be held on
  Tuesday, April 30, from 7 a.m. to 8:30 a.m. This activity is supported
  by an education grant from Takeda Pharmaceuticals U.S.A. Inc.
• Hereditary Transthyretin Amyloidosis (hATTR), which will
  be held on Tuesday, April 30, from 7 a.m. to 8:30 a.m. This
  activity is supported by an education grant from Alnylam
  Pharmaceuticals Inc.
• Antiviral Treatment of Influenza, which will be held on
  Tuesday, April 30, from noon to 1:30 p.m. This activity is supported
  by an education grant from Genentech.
• Von Willebrand Disease, which will be held on
  Wednesday, May 1, from 7 a.m. to 8:30 a.m. This activity is supported
  by an education grant from Grifols.
• Peanut Allergies, which will be held on
  Wednesday, May 1, from 7 a.m. to 8:30 a.m. This activity is supported
  by an education grant from Aimmune Therapeutics.
• Idiopathic Pulmonary Fibrosis, which will be held on
  Wednesday, May 1, from noon to 1:30 p.m. This activity is supported by
  an education grant from Genentech.
• Amyotrophic Lateral Sclerosis, which will be held on
  Wednesday, May 1, from noon to 1:30 p.m. This activity is supported by
  an education grant from Mitsubishi Tanabe Pharma America, Inc.
• Diabetic Retinopathy and Diabetic Macular Edema, which will
  be held on Thursday, May 2, from 7 a.m. to 8:30 a.m. This
  activity is supported by an education grant from Genentech.
• PARP Inhibitors in Ovarian Cancer, which will be held on
  Thursday, May 2, from 7 a.m. to 8:30 a.m. This activity is supported
  by an education grant from Tesaro.
• Chronic Thromboembolic Pulmonary Hypertension (CTEPH), which will
  be held on Thursday, May 2, from noon to 1:30 p.m. This
  activity is supported by an education grant from Actelion.
• Chronic Lymphocytic Leukemia, which will be held on
  Thursday, May 2, from noon to 1:30 p.m. This activity is supported by
  an education grant from AstraZeneca.

“Positioned at the epicenter of the industry, Asembia’s Summit is an
essential event for everyone involved in specialty pharmacy,” said
Robert Irene, RPh, president of Asembia. “The value-packed 2019 agenda
includes a wide variety of business and educational sessions from
industry experts as well as engaging exhibits and unparalleled
networking events.”

Accredited by the Accreditation Council for Pharmacy Education, each PTCE
session provides attendees with the opportunity to earn up to 1.5
continuing education credits. For more information and to register,
click here.

About Pharmacy Times Continuing Education™

Pharmacy Times Continuing Education™ (PTCE) is a
leader in continuing education for retail, health-system, managed care
and specialty pharmacists. PTCE is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing
pharmacy education (CPE). PTCE’s print, online and live CPE
activities are designed to help improve the knowledge, competence and
skills of pharmacists so they are better prepared to provide the highest
quality of pharmacy care to the patients they serve and to the
physicians they assist as part of a multidisciplinary
treatment/management team. To learn more about the educational
activities sponsored by PTCE, visit our website at https://www.pharmacytimes.org/.

About Asembia

Asembia works with member pharmacies, manufacturers, prescribers,
payers, and other industry stakeholders to develop solutions for the
high-touch specialty pharmaceutical service model. Through collaborative
programs, contracting initiatives, patient support HUB services and
innovative technology platforms, Asembia is committed to providing
solutions that impact the patient journey. Asembia is also founder and
host of the nation’s leading healthcare conference focused on increasing
the quality of patient care through specialty pharmaceutical services.
For more information, visit www.asembia.com.

Contacts

PTCE Media Contacts
Alexandra Ventura,
609-716-7777, ext. 121
[email protected]

John Patricolo, 609-325-4630
[email protected]